Skip to main content
David Schuster, MD, Radiology, Atlanta, GA

David Michael Schuster MD

Nuclear Cardiology, Nuclear Medicine, Nuclear Radiology


Professor, Radiology & Imaging Sciences, Emory University School of Medicine

Join to View Full Profile
  • Emory University Hospital1364 Clifton Road, Room E145Atlanta, GA 30322

  • Phone+1 404-712-4859

Dr. Schuster is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterResidency, Radiology-Diagnostic, 1988 - 1992
  • Albany Medical Center
    Albany Medical CenterInternship, Internal Medicine, 1987 - 1988
  • Albany Medical College
    Albany Medical CollegeClass of 1987

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1998 - 2026
  • GA State Medical License
    GA State Medical License 1996 - 2025
  • MA State Medical License
    MA State Medical License 1988 - 1997
  • Nuclear Medicine
    American Board of Nuclear Medicine Nuclear Medicine
  • Diagnostic Radiology
    American Board of Radiology Diagnostic Radiology
  • Nuclear Radiology
    American Board of Radiology Nuclear Radiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Imaging of Prostate Cancer Using Fluciclovine  
    David Schuster, MD, ScienceDirect

Authored Content

  • Y90 Radioembolization Dosimetry Using a Simple Semi-Quantitative Method in Intrahepatic Cholangiocarcinoma: Glass Versus Resin MicrospheresJanuary 2018

Press Mentions

  • Radiotracer Use Boosts Prostate Cancer Outcomes
    Radiotracer Use Boosts Prostate Cancer OutcomesMay 14th, 2021
  • Telix Pharmaceuticals and Emory Winship Cancer Institute to Collaborate on Clinical Trial Using Advanced Imaging of Prostate Cancer for Radiotherapy
    Telix Pharmaceuticals and Emory Winship Cancer Institute to Collaborate on Clinical Trial Using Advanced Imaging of Prostate Cancer for RadiotherapyMay 30th, 2019
  • FDA Approves Emory-Developed Prostate Cancer Imaging Probe
    FDA Approves Emory-Developed Prostate Cancer Imaging ProbeJune 1st, 2016
  • Join now to see all

Grant Support

  • Advanced PET-CT Directed Post-Prostatectomy Radiotherapy to Enhance Prostate Cancer OutcomesEMORY UNIVERSITY2019–2025
  • Anti-[18 F] Facbc PET-CT For Characterization Of Primary Prostate CarcinomaNational Cancer Institute2008–2011
  • 18f-Facbc PET-CT For The Detection And Staging Of Recurrent Prostate CarcinomaNational Cancer Institute2007–2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: